Delivery Order SPE2DB22D3016-SPE2DB25FBHD6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,673.88 to AmerisourceBergen Drug Corp for the supply of Trintellix 20 mg tablets (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,427.12 for 30 tablets of Trintellix 20 mg on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trintellix is a psychiatric medication used to treat major depressive disorder, reflecting the breadth...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.42 to AmerisourceBergen Drug Corp for Trintellix 5 mg tablets (30-count packages) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trintellix 20 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $2,747.66, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract was completed on August 8, 2025, with performance fulfilled at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.34 for 30 tablets of Trintellix 20 mg, a prescription antidepressant used to treat major depressive disorder. This firm fixed price delivery order, awarded on August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award involved no set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,442.25, is for the delivery of Trintellix 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a $3,747.43 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 10 mg tablets. The contract has a completion date of May 2, 2022 and is a firm fixed-price agreement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. Both companies are for-profit organizations registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order valued at $1,621.39 to AmerisourceBergen Drug Corp for 30 tablets of Trintellix 5 mg, a pharmaceutical product used in the treatment of major depressive disorder. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 12, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trintellix 5 mg tablets, a neurological medication. The contract has a ceiling value of $5,833.39 and a period of performance through April 23, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHD6Delivery Order
This delivery order, awarded September 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Trintellix 20 mg tablets (30-count) with a firm fixed price ceiling value of $1,697.73 and an ultimate completion date of September 5, 2025. The award is issued under a non-set-aside competitive procurement and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. This primary IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates significant capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Trintellix, a psychiatric medication used primarily for depression treatment, exemplifies the company's role in meeting federal pharmaceutical supply requirements through competitive, firm-fixed-price delivery mechanisms under the DLA's established prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/4/25 |